Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2004
06/03/2004WO2002102846B1 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state
06/03/2004WO2002097108A3 Antisense modulation of dual specific phosphatase 5 expression
06/03/2004WO1997035010A8 Chemokine alpha 2
06/03/2004US20040107453 Multipotent adult stem cells, sources thereof, methods of obtaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
06/03/2004US20040106778 Interferon gamma-like protein
06/03/2004US20040106637 detecting the presence or absence of increased S6 kinase activity in said biological sample.
06/03/2004US20040106571 modulator of tumor growth and metastasis in certain cancer types, especially breast and lung cancer
06/03/2004US20040106568 Nucleic acid sequences containing unmethylated CpG dinucleotides that modulate an immune response including stimulating a Th1 pattern of immune activation, cytokine production, NK lytic activity, and B cell proliferation
06/03/2004US20040106565 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells
06/03/2004US20040106541 Protein complex from ion-exchange chromatography for treatment of bacterial infections
06/03/2004US20040106540 Method of treating cancer
06/03/2004US20040106216 Immunoassay of hydroxysteroid dehydrogenase, and aromatase, biochemical immobilization, bioassay with antibodies
06/03/2004US20040106210 Detection of infections in liquid samples by detecting fatty acids present in the headspace associated with the liquid sample
06/03/2004US20040106209 Analyzing, detecting oxygen consumption, metabolic activity of cells, tissure samples, using luminescent compound, computer calibration, evaluting the data, cytochrome P450's catalyzing the oxidative reaction, use for drug development
06/03/2004US20040106200 Whole-body optical imaging of gene expression and uses thereof
06/03/2004US20040106197 Central nerve system precursor cells inducing synaptogenic neurons in spinal cord
06/03/2004US20040106194 Genetically engineered gene transfer vector comprising mutiple viral serotype sequences and E4 region of preferential virus for use as transfer tool in gene therapy and vaccine preparation
06/03/2004US20040106190 Flow-through assay devices
06/03/2004US20040106186 Gamma-sterilisable nutrient medium based on casein soya peptone agar
06/03/2004US20040106167 Using multiangle light scattering to detect physical changes in morphology of spores exposed to sterilants and identifying modifications associated with decreased viability
06/03/2004US20040106166 Enzyme electrode and process for manufacturing the same
06/03/2004US20040106165 Screening method for detecting amidase and nitrile hydratase activity and use thereof
06/03/2004US20040106164 Analyzing microorganism associated with an enzyme in a sample water, food, soil, or a biological sample, enzyme-linked immunosorbent assay, automatic detect fluorescence with optical fiber, separate with polydimethylsiloxane films; diagnostic kits
06/03/2004US20040106160 Screening assay for antagonists of human leukocyte receptors
06/03/2004US20040106159 Using protein fragments to induce cytokine response in CD8 and/or CD4 lymphocytes; screening mammals for previous exposure to antigens
06/03/2004US20040106158 employing as reagents a conjugate of IP3 joined at the 2-oxy through a bond or linking group to a detectable label and a truncated portion of the extracellular fragment of an IP3R
06/03/2004US20040106156 Methods and compositions for detecting receptor-ligand interactions in single cells
06/03/2004US20040106154 In vivo screen using chemical inducers of dimerization
06/03/2004US20040106149 Novel gpcr hfrbn63
06/03/2004US20040106145 Method and apparatus for the automated generation of nucleic acid ligands
06/03/2004US20040106144 Method for monitoring the temperature of a biochemical reaction
06/03/2004US20040106143 Monoclonal antibody against estrogen stimulated leucine aminopeptidase
06/03/2004US20040106142 Evaluating nucleic acid sequences and identifying systemic inflammatory response syndrome
06/03/2004US20040106141 Methods and materials for examining pathways associated with glioblastoma progression
06/03/2004US20040106140 comprising selection or isolation of heteroduplexes containing at least one internal single stranded region with a single stranded trap, using Recognition Element that is benzoylated-naphthoylated-DEAE-cellulose
06/03/2004US20040106138 Detecting missence mutation in nucleotide sequences coding protein kinase c; diagnosis and treatment of nervous system disorders; drug screening
06/03/2004US20040106137 Comprises nucleotide sequences coding heat resistant single stranded DNA binding protein comprising polymerases activity for use as replication tool in genetic engineering
06/03/2004US20040106136 Method for testing drug susceptibility of HIV
06/03/2004US20040106135 Identifying peroxisome proliferator activated receptor (PPAR) modulator for use in treatment and prevention of hyperlipidemia and liver disorders
06/03/2004US20040106134 Comprises genetically engineered immunoglobulin for use in the treatment of bone disorders
06/03/2004US20040106133 Method for detecting ammonia-oxidizing bacteria
06/03/2004US20040106132 Oligonucleotide for generating gene expression profiles in presence of enzyme inhibitors; cancer diagnosis and treatment; antisense therapy
06/03/2004US20040106129 Mass spectrometric methods for biomolecular screening
06/03/2004US20040106126 Sensor arrangement, device and method for testing active substances and/or active sites from a pharmacological point of view using an amperometer and/or potentiometer
06/03/2004US20040106125 Comprises neuronal polypeptides for diagnosis, treatment and prevention of autoimmune, inflammatory, cardiovascular, nervous system, developmental, cell proliferative, psychological and metabolic disorders
06/03/2004US20040106124 Identifying genotype for depressive episodes and modifying administration of antidepressants and adrenergic stimulants
06/03/2004US20040106120 Identifying nucleotide sequence changes/polymorphism associated with abnormal cell adhesion and treating skin, asthma and chronic obstruction pulmonary disease using enzyme inhibitors
06/03/2004US20040106114 Preparing supports comprised of uniquely colored probed modified microspheres comprising optical bar code for use in DNA analysis
06/03/2004US20040106113 Prediction of estrogen receptor status of breast tumors using binary prediction tree modeling
06/03/2004US20040106112 Nucleic acid detection medium
06/03/2004US20040106111 Identifying and characterizing chromosomal positioning/quantitative trait loci of genetc markers associated with boar taint; animal husbandry and genetic engineering
06/03/2004US20040106110 Apparatus comprising immobilized nucleotide for use in genetic and sequence analysis detection; genetic engineering and sequence determination
06/03/2004US20040106109 Restriction mediated selection polymerase chain reaction (REMS-PCR); DNA primers and probes for amplifying and determining ras mutationsin one or more nucleic acids including excess wild type
06/03/2004US20040106108 Solid support assay systems and methods utilizing non-standard bases
06/03/2004US20040106107 Extracellular matrix protein for identifying modulators for treatment of cancer, leukemia, solid tumors, nervous system, inflammation, restenotic, diabetic, arthritic and osteoporotic disorders
06/03/2004US20040106106 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors
06/03/2004US20040106103 Novel retrovirus associated with myelodysplastic syndromers and uses thereof
06/03/2004US20040106102 Using oligonucleotide template to detect and determine sequence of restriction fragment length polymorphisms on single or multiple chromosomes; genotyping
06/03/2004US20040106100 Dna vaccines encoding hiv accessory proteins
06/03/2004US20040106099 Using oligonucleotide probes to identify viral pathogens associated with liver inflammation and disorders
06/03/2004US20040106098 Using spectrum analysis to monitor and partition active pharmeceutical ingredients (API) which are highly viscous and in high concentrations; drug screening and interactions
06/03/2004US20040106095 Functional cardiomyocytes from human embryonic stem cells
06/03/2004US20040105865 Treatment and diagnosis of prostate cancer
06/03/2004US20040105863 Method to search for male antifertility drugs based on PHGPx activity determination
06/03/2004US20040104131 Test strip includes sample chamber, working and counter electrodes, fill-detect electrodes, and auto-on conductor; data processing and storage; accuracy
06/03/2004DE19842164B4 Verfahren zur Qualitätskontrolle beim Aufbau von Oligomerrastern Quality control procedures in the construction of Oligomerrastern
06/03/2004DE10253337A1 Verfahren zum Nachweis einer Nukleinsäure A method for detecting a nucleic acid
06/03/2004DE10246384A1 Fractionating nucleic acid into sequence-specific subgroups, useful for e.g. displaying DNA fragment subsets, by treatment with type IIs restriction enzyme, attaching adapter then selective amplification
06/03/2004DE10036931B4 Nachweis und Identifikation von Bakterienstämmen Detection and identification of bacterial strains
06/03/2004CA2599222A1 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia (b-cll)
06/03/2004CA2506751A1 Apparatuses and methods for assaying analytes using photoelectrochemical labels
06/03/2004CA2506737A1 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia (b-cll)
06/03/2004CA2506695A1 Genetic constructs and compositions comprising rre and cte and uses thereof
06/03/2004CA2506601A1 Genotyping of deafness by oligonucleotide microarray analysis
06/03/2004CA2506400A1 Methods and kits for assays of rapid screening of diabetes
06/03/2004CA2506331A1 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof
06/03/2004CA2506243A1 Amplified genes involved in cancer
06/03/2004CA2506129A1 2'-branched nucleosides and flaviviridae mutation
06/03/2004CA2506066A1 Gene expression profiling of egfr positive cancer
06/03/2004CA2506058A1 Nucleic acid probes and broad-range primers from regions in topoisomerase genes, and methods in which they are used
06/03/2004CA2505994A1 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
06/03/2004CA2505992A1 Absolute quantitation of nucleic acids by rt-pcr
06/03/2004CA2505907A1 Methods of biosensing using fluorescent polymers and quencher-tether-ligand bioconjugates
06/03/2004CA2505748A1 Diagnostic and therapeutic means for pathologies associated with alpha 2 subunit of the na, k pump
06/03/2004CA2505735A1 Methods for diagnosing the presence or stage of cancer
06/03/2004CA2505721A1 Rnai-based sensors, caged interfering rnas, and methods of use thereof
06/03/2004CA2505687A1 Polynucleotide sequence detection assays and analysis
06/03/2004CA2505636A1 Nucleic acid sequence detection
06/03/2004CA2505603A1 Caged sensors, regulators and compounds and uses thereof
06/03/2004CA2504930A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
06/03/2004CA2489360A1 Methods and compositions for determining methylation profiles
06/03/2004CA2485968A1 Method for predicting autoimmune diseases
06/03/2004CA2485560A1 Unique recognition sequences and methods of use thereof in protein analysis
06/02/2004EP1424555A1 Method and test kit for the detection of insecticide resistance in insect vectors
06/02/2004EP1424401A1 METHOD OF DETECTING, IDENTIFYING AND COUNTING ENTERITIS VIBRIO USING GENE (rpoD) SEQUENCES ENCODING RNA POLYMERASE SIGMA 70 FACTOR
06/02/2004EP1424400A1 Methods and kits for the selection of animals having certain milk production capabilities, based on the analysis of a polymorphism in the growth hormone receptor gene
06/02/2004EP1424391A1 Gene panel participating in liver astrocyte activation
06/02/2004EP1424341A2 Production method for purine nucleotide derivative disodium crystals and alcohol removing method
06/02/2004EP1423816A2 Basecalling system and protocol
06/02/2004EP1423707A1 Methods of screening molecules that are used to prevent cardiovascular diseases